Close Menu
LifePositive
    What's Hot

    Surya Namaskar (Sun Salutation): 12 Steps, Benefits and Safety Tips

    November 13, 2026

    Yoga for Agya Chakra: 7 Poses for Focus and Inner Awareness

    November 3, 2026

    Yoga for Anahata Chakra: 7 Heart-Opening Poses

    November 3, 2026
    Facebook X (Twitter) Instagram YouTube LinkedIn
    • Demos
    Facebook X (Twitter) Instagram LinkedIn YouTube
    Tuesday, November 17
    LifePositive
    Facebook X (Twitter) Instagram LinkedIn YouTube
    • Wellness
      • Mental Health
      • Healing
      • Nutrition & Healthy Eating
    • Meditation
    • Spirituality
    • Yoga
    • Personal Growth
    • Free Tarot
    • Environment
    • Banyan Tree
    • Other Categories
      • Alternative Therapies
      • Cure
      • Divine
      • Freedom
      • Healthcare Management
      • Holistic Health
      • Inspiration
      • Knowledge
      • Lifestyle
      • Metaphysical Sciences
      • Motivational
      • Parenting
      • Positive Journalism
      • Positivity
      • Spiritual Healing
      • Success Stories
      • Workplace Wellness
    LifePositive
    • Home
    Home - Blogs - Natural bacteria destroys cancer
    Personal Growth

    Natural bacteria destroys cancer

    Life PositiveBy Life PositiveSeptember 26, 2026Updated:November 6, 2026No Comments4 Mins Read
    Facebook Twitter LinkedIn
    Share
    Facebook Twitter LinkedIn Pinterest Email Copy Link

    Recently, a bacteria has been found in  frogs in Japan that destroys cancer in one dose. While this might sound like science fiction, it’s a real and historically rooted area of cancer research. The concept is simple: certain bacteria have an innate ability to seek out and thrive in tumors, where they can then attack the cancer directly and stimulate the body’s immune system to fight it.
    This field, known as bacterial or oncolytic bacterial therapy, has progressed from early observations to modern clinical trials. Here’s how it works and what’s happening in the field today.


    How Bacteria “Naturally” Destroy Cancer
    Bacteria possess several unique traits that make them promising anticancer agents. Their effectiveness comes from a combination of several key mechanisms:

    Inherent Tumor Targeting: Tumors have a unique environment—they are often low in oxygen (hypoxic), acidic, and have a chaotic blood supply. This is an ideal environment for many bacteria. Facultative anaerobes (like Salmonella) and obligate anaerobes (like Clostridium) can specifically target, colonize, and proliferate within these tumor sites while largely avoiding healthy tissues.

    Direct Tumor Lysis: Some bacteria, such as Photobacterium angustum and certain Clostridium species, can directly kill cancer cells. For instance, Clostridium can release toxins that damage cancer cell membranes, and research has shown P. angustum has an “intrinsic oncolytic activity” that contributes to direct tumor lysis.
    Immune System Activation: This is perhaps the most powerful mechanism. Bacteria are rich in molecules called pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharides (LPS). When bacteria colonize a tumor, these PAMPs act as a powerful signal to the immune system, triggering an intense and targeted immune response against the tumor. This is the same principle behind Bacillus Calmette-Guérin (BCG), a vaccine for tuberculosis that is now an FDA-approved standard treatment for non-muscle invasive bladder cancer.

    The Modern Frontier: Engineering for Precision
    While “natural” bacteria are effective, their potency can be limited or unpredictable. Today, scientists use genetic engineering to create even more powerful and safer “designer” bacteria. This approach has several advantages:
    Enhanced Safety: Harmful genes are removed to create “attenuated” strains that are safe for patients but still effective.
    Targeted Payload Delivery: Engineered bacteria can be programmed to deliver therapeutic payloads directly to the tumor, such as:
    Cytokines (like IL-2) that boost the immune response.
    Prodrug-converting enzymes that activate chemotherapy drugs only within the tumor, reducing systemic side effects.
    Tumor antigens to train the immune system to recognize and attack cancer cells.

    Programmable Control: Using synthetic biology, bacteria are equipped with genetic circuits that can sense the tumor environment and release their payload only at the right time and place.

    Promising Bacteria in Research and Clinical Trials
    This is not just a laboratory concept. Several bacteria strains are currently being studied or are in clinical trials for various cancers. Here are some key examples:
    Bacterial Strain
    Key Mechanism / Approach

    Cancer Types
    Status / Phase
    Salmonella typhimurium (e.g., VNP20009)
    Tumor targeting, immune activation, and drug delivery
    Advanced solid tumors, metastatic pancreatic cancer
    Clinical Trials (Phase I/II)
    Clostridium novyi-NT
    Obligate anaerobe that colonizes tumor hypoxic zones, causing tumor lysis and immune response
    Refractory solid tumors
    Clinical Trials (Phase I)
    Listeria monocytogenes (e.g., CRS-207, ADXS11-001)
    Infects and kills cancer cells, activates strong T-cell responses
    Pancreatic, cervical, lung cancer, mesothelioma
    Clinical Trials (Phase I/II/III)
    Bifidobacterium longum
    Probiotic that thrives in hypoxic tumors
    Advanced solid tumors

    Clinical Trials (Phase I/II)
    Photobacterium angustum
    A naturally marine bacterium with strong tumor tropism and direct oncolytic activity
    Colorectal cancer (preclinical)
    Preclinical
    Escherichia coli Nissle 1917 (e.g., SYNB1891)
    Engineered probiotic for intratumoral injection; stimulates STING pathway
    Advanced solid tumors, lymphoma
    Clinical Trials (Phase I)
    Proteus mirabilis (PM) & Rhodopseudomonas palustris (RP)
    A bacterial consortium with strong immunogenic oncolytic efficacy
    Colorectal, sarcoma, lung, breast cancer (preclinical)

    Preclinical

    A note on clinical trials: While early studies have shown these therapies are feasible and have manageable side effects in some cases, many natural and engineered strains in early-stage trials have shown limited efficacy as a monotherapy. This highlights that the field is still in its early stages, but it also points to the next steps, like combining bacterial therapy with other treatments like checkpoint inhibitors to unlock its full potential.
    We hope this takes place soon to save the lives of many patients.

    By Jamuna Rangachari

    Share. Facebook Twitter LinkedIn
    Previous ArticleNorway on the verge of completing the longest underwater tunnel
    Next Article Naturopathy Complements Cancer Treatment: The Role of Nutrition & Lifestyle Support
    Life Positive
    • Website

    Add A Comment
    Leave A Reply Cancel Reply

    TRENDING POST

    Surya Namaskar (Sun Salutation): 12 Steps, Benefits and Safety Tips

    November 13, 2026

    Yoga for Agya Chakra: 7 Poses for Focus and Inner Awareness

    November 3, 2026

    Yoga for Anahata Chakra: 7 Heart-Opening Poses

    November 3, 2026

    When the Search Within Becomes a Way of Life

    September 26, 2026

    When the Mind Finds Stillness: The Healing Power of Meditation

    September 26, 2026

    Search of a Spiritual Scientist: Journey of a Scientist Self-Realisation

    September 26, 2026

    A-32, 2nd Floor, Mohan Co-operative Industrial Estate, Mathura Road, New Delhi-110044

    +91 – 11 – 49563721

    info@lifepositive.net

    Facebook X (Twitter) Instagram YouTube LinkedIn
    Menu
    • Meditation
    • Spirituality
    • Yoga
    • Personal Growth
    • Health
    • Environment
    • Free Tarot
    Useful Links
    • Home
    • About Us
    • Testimonials
    • Contact Us
    • Terms and Conditions
    • Privacy Policy
    • Returns and Refunds Policy
    • Home
    © 2026 LifePositive

    Type above and press Enter to search. Press Esc to cancel.